Other Clients/Companies To Watch:

Access Pharmaceuticals, Inc
(OTC: ACCP)

Aedeona
(AMEX:AEN)

Alexza Pharmaceuticals, Inc.
(NASDAQ:ALXA)

Cardiogenics Holdings, Inc.
(OTC:CGNH)

Crucell N.V.
(Euronext, NASDAQ: CRXL)

Digital Angel Corporation
(AMEX:DOC)

Dynavax Technologies Corporation
(NASDAQ:DVAX)

Elan Corporation
(NYSE: ELN)

Galapagos NV
(Euronext:GLPGA)

KERYX Biopharmaceuticals, Inc.
(NASDAQ:KERX)

Lpath, Inc.
(OTC:LPTN)

Manhattan Pharmaceuticals, Inc.
(AMEX:MHA)

Mediware Information Systems, Inc. (NASDAQ: MEDW)

Redpoint Bio Corporation
(OTC:RPBC)

VIA Pharmaceuticals, Inc.
(NASDAQ: VIAP)

ZIOPHARM, INC.
(NASDAQ:ZIOP)

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious diseases. The Company's lead product candidate is HEPLISAV, an investigational adult hepatitis B vaccine designed to enhance protection more rapidly and with fewer doses than current licensed vaccines. For more information visit www.dynavax.com.

AT A GLANCE | COMPANY NEWS | COMPANY WEBSITE |SEC FILINGS | STOCK QUOTE